Fettsyrer - potensielle risikofaktorer for tarmkreft.
- Prosjektnummer
- 2007021
- Ansvarlig person
- Morten H. Vatn
- Institusjon
- Akershus universitetssykehus HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Inflammatory and Immune System
- Forskningsaktivitet
- 4. Detection and Diagnosis
Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients.
J Oncol 2012;2012():254801. Epub 2012 des 23
PMID: 23319946
Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP.
Fam Cancer 2010 Dec;9(4):571-80.
PMID: 20593240
Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway.
Eur J Nutr 2009 Apr;48(3):129-36. Epub 2009 jan 13
PMID: 19142564
A double bind placebo controlled assessment of mucosal changes of the duodenum in patients with familial adenomatous polyposis(F
Annals of Hepatology and Gastrtoenterology 2012
A Double- Blind Placebo-Controlled Assessment of Endoscopic Change and Duodenal Cox-2 Expression in PAtients with Familial Adeno
Annals of Gastroenterology and Hepatology, 2012;3:1-7
A double-blind Placebo-controlled assessment of endoscopic change and duodenal Cox-2 expression in patients with FAP
2011;2:000-000
DNA Sequence profiles of the colorectal cancer critical gene set kras-braf-pik3ca-pten-tp53related to age at disease onset
PLoS ONE 2010;5:e13978,1-8
A double bind placebo controlled assessment of mucosal changes of the duodenum in patients with familial adenomatous polyposis(F
Gastroenterology 2009;135:suppl.1
Fifteen days of seafood consumption alters blood lipid profile and gene expression in peripheral blood mononuclear cells
Poster på EAS konferanse i Istanbul, april 2008
Expression of COX-1 and COX-2 in PBMCs and leukocytes, isolated from healthy subjects.
Poster på NuGO konferanse i Oslo, høsten 2007
Inerleukin-33 in inflammation and wound repair : an experimental study with special reference to endothelial cells and myofibrob
- Disputert:
- juni 2012
- Hovedveileder:
- Guttorm Haraldsen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport